 NEWARK, Calif., Sept. 09, 2021 GLOBE NEWSWIRE -- Rain Therapeutics Inc. NasdaqGS: RAIN Rain, a late-stage company developing precision oncology therapeutics, today announced that Avanish Vellanki, co-founder, chairman and chief executive officer of Rain, will present at the H.C. Wainwright 23rd Annual Global Investment Conference being held virtually September 13-15, 2021. 